Impact of Sodium‐Glucose Co‐Transporter 2 Inhibitors on Atrial Fibrillation Recurrence Post‐Catheter Ablation Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

Documenti analoghi

• Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome
  di: Yang Xu, et al.
  Pubblicazione: (2025)
• Reconsidering the Antiarrhythmic Role of Sodium–Glucose Cotransporter‐2 Inhibitors After Atrial Fibrillation Ablation
  di: Muhammet Cihat Çelik, et al.
  Pubblicazione: (2025)
• Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation
  di: Ghee Kheng Lim, et al.
  Pubblicazione: (2025)
• Commentary on “Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
  di: Pouya Tayebi, et al.
  Pubblicazione: (2025)
• Letter to the Editor: Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation
  di: Syed Ali Raza Zaidi, et al.
  Pubblicazione: (2025)